🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
1.250
-0.140 (-10.07%)
Nov 20, 2026, 4:00 PM EST - Market closed

Tenax Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
22.5423.716.795.015.686.38
Research & Development
4732.6712.713.235.3825.15
Operating Expenses
69.5356.3919.498.2311.0531.53
Operating Income
-69.53-56.39-19.49-8.23-11.05-31.53
Interest Expense
---0.02-0.02-0-0
Interest & Investment Income
3.83.821.910.48--
Other Non Operating Income (Expenses)
-0.03-0.0300.060.010.02
EBT Excluding Unusual Items
-65.76-52.6-17.6-7.71-11.05-31.51
Gain (Loss) on Sale of Investments
------0.01
Gain (Loss) on Sale of Assets
----0-
Other Unusual Items
------0.95
Pretax Income
-65.76-52.6-17.6-7.71-11.05-32.47
Net Income
-65.76-52.6-17.6-7.71-11.05-32.47
Net Income to Common
-65.76-52.6-17.6-7.71-11.05-32.47
Net Income Growth
------
Shares Outstanding (Basic)
483915000
Shares Outstanding (Diluted)
483915000
Shares Change
25.24%156.80%6046.87%1250.92%43.00%-
EPS (Basic)
-1.38-1.34-1.15-31.04-600.72-2525.03
EPS (Diluted)
-1.38-1.34-1.15-31.04-600.72-2525.03
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-49.35-35.8-14.81-5.9-11.39-10.86
Free Cash Flow Per Share
-1.04-0.91-0.97-23.76-619.37-844.53
EBITDA
---19.49-8.23-11.05-31.52
D&A For EBITDA
--0.010.010.010
EBIT
-69.53-56.39-19.49-8.23-11.05-31.53
SEC Filings: 10-K · 10-Q